Navigation Links
SGX Pharmaceuticals Provides Update on SGX523 Clinical Trials
Date:3/27/2008

Company Presents Today at BioCentury Future Leaders Conference

SAN DIEGO, March 27 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP) is providing an update today on the SGX523 clinical program.

In January 2008, the Company initiated two parallel, multi-center Phase 1 clinical trials of SGX523 in patients with solid tumor cancers. The first trial has been designed to examine twice daily, oral dosing on a continuous 28-day cycle and the second trial has been designed to examine interrupted dosing (a repeating 21 day cycle of 14 days on therapy followed by 7 days off).

In both trials, the Company observed dose limiting toxicity earlier than anticipated. The toxicity is of a nature that was not anticipated based on the preclinical profile of SGX523. The interrupted dosing trial started at a higher dose than the continuous dosing trial and no patients are currently receiving treatment on the interrupted dosing trial. In the continuous dosing trial, patients are continuing to be treated at a lower dose level, and the Company is evaluating the safety and efficacy of treatment at that dose level.

"From the initial clinical data, the profile of SGX523 appears to be different than the preclinical data would suggest," said Mike Grey, president and chief executive officer of SGX Pharmaceuticals. "On the continuous dosing trial, patients continue on study at the initial dose and we may explore whether alternative doses and schedules are safe and efficacious. We continue the preclinical development of the BCR-ABL inhibitor SGX393 and the second MET inhibitor SGX126. In addition, we are targeting the identification of two development candidates this year from our drug discovery programs to further enhance our pi
'/>"/>

SOURCE SGX Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call
2. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
3. Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
4. XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
5. SGX Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
6. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
7. LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series C Financing Round
8. Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
9. Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results
10. MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
11. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014  Neogen Corporation (Nasdaq: ... first quarter of its 2015 fiscal year, which ended ... to net income of $7,839,000 in the first quarter ... effective Oct. 30, 2013, earnings per share in the ... ago. First quarter revenues increased 15% to ...
(Date:9/22/2014)... -- The US markets on Friday, September ... Dow Jones Industrial Average finished at 17,279.74, up 0.08% ... The S&P 500 finished the session 0.05% lower at ... sectors finished on a positive note. The S&P 500 ... up 0.10%, with the index gaining 6.95% in the ...
(Date:9/22/2014)... , Sept. 22, 2014  Spherix Incorporated (SPEX) -- ... monetization of intellectual property, today announced that the United States ... the Company in the month of September that is part ... The issued patent is: USRE45,121 , Application number: ... , Filing date: Dec 27, 2012 The ...
(Date:9/21/2014)... September 21, 2014 Chemical Sciences ... challenges such as clean air and safe water, ... natural products. Chemists, environmentalists, food scientists, educators, and ... research in the field of Chemistry for the ... Sciences is one of the fastest emerging Sciences, ...
Breaking Biology Technology:Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 4Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 5Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3Chemistry for Global Development during the Open Access Week 2Chemistry for Global Development during the Open Access Week 3
... New Report Added in ResearchMoz Reports ... Spending Estimates and Forecasts) The ... past ten years suggests the amount of vaccine production ... adapt to match a revived industry. This ...
... 15, 2012 Healthcare organizations are becoming more efficient ... creating a more connected patient care environment. But to ... information, especially the electronic medical record (EMR) and enterprise ... Software, a leader in ECM for healthcare , ...
... improve infrared photodetector technology that is critical to national ... in commercial applications and consumer products. A significant ... journal Applied Physics Letters . It ... more effectively by using certain materials arranged in specific ...
Cached Biology Technology:ResearchMoz: Vaccine Production Market (Trends, Techniques, Key Players, Spending Estimates and Forecasts) 2ResearchMoz: Vaccine Production Market (Trends, Techniques, Key Players, Spending Estimates and Forecasts) 3ResearchMoz: Vaccine Production Market (Trends, Techniques, Key Players, Spending Estimates and Forecasts) 4ResearchMoz: Vaccine Production Market (Trends, Techniques, Key Players, Spending Estimates and Forecasts) 5Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System 2Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System 3New nano-material combinations produce leap in infrared technology 2New nano-material combinations produce leap in infrared technology 3
(Date:9/19/2014)... not evolve for the sake of fairness per se ... cooperation, so say Frans de Waal, PhD, and Sarah ... aversion (IA), which is defined as a negative reaction ... Science . , Their conclusion comes after the ... their hypothesis that it is the evolution of forestalling ...
(Date:9/19/2014)... study shows that legume plants regulate their symbiotic ... that are transmitted through the plant structure from ... of bacteria-holding nodules in the roots. This collaborative ... Institute for Basic Biology, the Graduate University for ... Sustainable Resource Science in Japan. , Legumes, ...
(Date:9/18/2014)... A sleep-promoting circuit located deep in the primitive brainstem ... by researchers at Harvard School of Medicine and the ... this is only the second "sleep node" identified in ... necessary and sufficient to produce deep sleep. , Published ... study demonstrates that fully half of all of the ...
Breaking Biology News(10 mins):Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3For legume plants, a new route from shoot to root 2No sedative necessary: Scientists discover new 'sleep node' in the brain 2
... sunlight decreases the toxicity of golden algae, which kills millions ... While golden algae is primarily a coastal species, it has ... and Lake Waco in Central Texas, and Lake Granbury in ... production, but new research from Baylor scientists shows that sunlight ...
... International and American Associations for Dental Research (IADR/AADR) have ... and Pulp Regeneration," held in Geneva, Switzerland, July 2010. ... and Regeneration Group, and they are published in volume ... an E-supplement to the Journal of Dental Research ...
... CAMBRIDGE, Mass. -- The first organisms to emerge ... skills, arming themselves with tough exteriors to weather a ... Smith College have discovered hundreds of microscopic fossils in ... time when the planet emerged from a global glaciation, ...
Cached Biology News:IADR/AADR publish proceedings from Symposium on Tissue Injury and Pulp Regeneration 2MIT research: Life after 'Snowball Earth' 2MIT research: Life after 'Snowball Earth' 3
Panomer 9 oligodeoxynucleotides are random primers that are labeled at the 5' end with our proprietary QSY 7 dye and they are useful for assessing microarray spot morphology, hybridization potential ...
... l-[U-14C]methionine, 1.85 MBq, 50 uCi. Aqueous ... > 1.85 GBq/mg atom carbon, > ... of Ala, Arg, Asp, Glu, Gly, ... Ser, Thr, Tyr and Val.1.85 MBq/ml, ...
Topoisomerase I, isolated from wheat germ, is an enzyme capable of removing negative supercoils from covalently closed circular DNA (1)....
Request Info...
Biology Products: